1 After long-term n-hexane exposure (2000 ppm, 12 h d-1, 6 d week-1, for 24 weeks), the content of neuron-specific enolase (gamma-enolase), creatine kinase-B and beta-S100 protein in the cortex, cerebellum, spinal cord and proximal and distal sciatic nerves of rats was determined by enzyme immunoassay.
2 The amounts of the three proteins decreased significantly in the distal segment of sciatic nerve, whereas they remained unchanged in the brain and proximal sciatic nerve. The quantitative decline in these marker proteins in the distal sciatic nerve could be related to neurophysiological deficits in the peripheral nerves.
3 This study indicates that the biochemical changes observed are consistent with the clinical and pathological findings of n-hexane neuropathy. These nerve-specific marker proteins can be used to assess solvent-related peripheral neurotoxicity.
Get full access to this article
View all access options for this article.
References
1.
Isobe T., Ichimura T. & Okuyama T.Nervous system-specific proteins. Protein, Nucleic Acid and Enzyme1990; 35: 597-611.
2.
Kato K.Enzyme immunoassay and nervous tissue-related proteins. Protein, Nucleic Acid and Enzyne1990; 35: 612-21.
3.
Kato K. & Satoh T.Changes in the concentration of enolase isozyme and S-100 protein in degenerating and regenerating rat sciatic nerve. Journal of Neurochemistry1983; 40: 1076-81.
4.
Huang J., Kato K., Shibata E. et al. Effects of subacute toluene exposure on neuronal and glial marker proteins in rat brain. Toxicology1990; 61: 109-117.
5.
Huang J., Asaeda N., Takeuchi Y. et al. Dose-dependent effects of chronic exposure to toluene on neuronal and glial cell marker proteins in the central nervous system of rats. British Journal of Industrial Medicine1992; (in press).
6.
Takeuchi Y., Huang J., Shibata E., Hisanaga N. & Ono Y.A trial to automatize an organic solvent exposure system for small animals . Proceedings of the 62nd meeting of the Japanese Association of Occupational Health, Aomori, p 328. 1989.
7.
Kato K., Suzuki F. & Umeda Y.Highly sensitive Immunoassays for three forms of rat brain enolase . Journal of Neurochemistry1981; 36: 793-7.
8.
Kato K., Nakajima T., Ishiguro Y. & Matsutani Y.Sensitive enzyme immunossay for S-100 protein: determination in human cerebrospinal fluid. Biomedical Research1982 ; 3: 24-8.
9.
Kato K., Suzuki F., Shimizu A., Shinohara H. & Semba R.Highly sensitive immunoassay for rat brain-type creatine kinase: determination in isolated Purkinje cells. Journal of Neurochemistry1986; 46: 1783-8.
10.
Bradford MMA rapid and sensitive method for the quantitation of microgram quantitives of protein utilizing the principle of protein-dye binding. Annals of Biochemistry1976; 72: 248-54.
11.
Takeuchi Y. , Ono Y., Hisanaga N., Kitoh J. & Sugiura Y.A comparative study on the neurotoxicity of n-pentane, n-hexane, and n-heptane in the rat . British Journal of Industrial Medicine1980 ; 37: 241-7.
12.
Spencer PS & Schaumburg HHUltrastructural studies of the dying-back process. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies . Journal of Neuropathology and Experimental Neurology1977; 36: 300-20.
13.
Howland RDThe etiology of acrylamide neuropathy: enolase, phosphofructokinase, and glyceraldehyde-3-phosphate dehydrogenase activities in peripheral nerve, spinal cord, brain, and skeletal muscle of acrylamide-intoxicated cats. Toxicology and Applied Pharmacology1981; 60: 324-33.
14.
Couri D. & Milks MMHexacarbon neuropathy: tracking a toxin. Neurotoxicology1985; 6: 65-72.
15.
Spencer PS, Sabri MI, Schaumburg HH & Moore CLDose defect of energy metabolism in the nerve fibers underlie axonal degeneration and polyneuropathies?Annals of Neurology1979; 5: 501-7.
16.
Brady ST & Lasek RJNerve-specific enolase and creatine phosphokinase in axonal transport: soluble proteins and the axoplasmic matrix. Cell1981 ; 23: 515-23.
17.
Miani N., Renzis GD, Michetti F. et al. Axonal transport of S-100 protein in mammalian nerve fibres . Journal of Neurochemistry1972; 19: 1387-94.
